ARTICLE | Clinical News
ALM AADx: Clinical trial data
July 21, 2014 7:00 AM UTC
Data from a validation study analyzing 283 samples from patients with high-grade serous ovarian cancer showed that Almac’s ALM AADx assay identified a subgroup of patients with a better prognosis for ...